Research Projects

Project Code Project Name
NK Cells Study Characterization of innate Natural Killer Cells in Early HIV infection
Protocol O Human Explant Model to Study Immune Responses Associated with HIV-1 Infection
HIV Paed Drug Study A Phase II, open label, single arm trial to evaluate the pharmacokinetics, safety, tolerability, and antiviral activity of rilpivirine (TMC278) in antiretroviral naïve HIV-1 infected adolescents and children aged ≥6 to <18 years
WHO/STI Determining the Causes of Genital Discharge and Establishment of Sub-regional Reference Laboratory to support Gonococcal Antimicrobial Surveillance Programme in Africa
VZV Study An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya
Stem Cell study Establishment of assays for culture and manipulation of haematopoietic stem cells from cord blood and adipose cells-
Ebola 2 A Randomized, Observer-blind, Placebo-controlled, Phase 2 Study to Evaluate the Safety, Tolerability and Immunogenicity of Three Prime-boost Regimens of the Candidate Prophylactic Vaccines for Ebola Ad26.ZEBOV and MVA-BN-Filo in Healthy Adults, Including
K001 Pre-screening of volunteers for potential participation in future clinical research (observational studies and clinical trials) at KAVI
L015 Characterization of population specific immune responses in support of HIV vaccine trials
IAVI LTFU Long Term Follow-up of study participants from IAVI sponsored clinical trials with HIV candidate vaccines